(Reuters) - Taken once or twice daily for six days beginning two days
before the start of a woman's menstrual period, the drug
significantly increased the number of headache-free periods
compared with women who received a placebo, researchers said.
Frova also significantly reduced the incidence of severe
migraines, according to data from the 410-patient study,
presented at the American Headache Society annual meeting in
Chicago on Saturday.
Read more at Reuters.com Government Filings News
before the start of a woman's menstrual period, the drug
significantly increased the number of headache-free periods
compared with women who received a placebo, researchers said.
Frova also significantly reduced the incidence of severe
migraines, according to data from the 410-patient study,
presented at the American Headache Society annual meeting in
Chicago on Saturday.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment